Take off with UnitedHealth Group Incorporated (UNH): Get ready for trading

UnitedHealth Group Incorporated (NYSE: UNH) stock fell -1.28% on Friday to $533.75 against a previous-day closing price of $540.65. With 2.36 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.36 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $540.43 whereas the lowest price it dropped to was $532.76. The 52-week range on UNH shows that it touched its highest point at $553.29 and its lowest point at $383.12 during that stretch. It currently has a 1-year price target of $572.87. With its current market cap of 493.61 billion, UNH has annualized dividend of $6.60 while the current yield stands at 1.24%. Beta for the stock currently stands at 0.77.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UNH was down-trending over the past week, with a drop of -1.43%, but this was up by 3.58% over a month. Three-month performance surged to 5.15% while six-month performance rose 11.25%. The stock gained 26.62% in the past year, while it has gained 6.30% so far this year. A look at the trailing 12-month EPS for UNH yields 19.14 with Next year EPS estimates of 24.86. For the next quarter, that number is 5.43. This implies an EPS growth rate of 12.80% for this year and 13.59% for next year. EPS is expected to grow by 14.42% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 20.10%.

Float and Shares Shorts:

At present, 941.00 million UNH shares are outstanding with a float of 932.93 million shares on hand for trading. On Jul 14, 2022, short shares totaled 5.68 million, which was 0.61% higher than short shares on Jun 14, 2022. In addition to Sir Andrew Philip Witty as the firm’s CEO & Director, Mr. Dirk C. McMahon serves as its Pres & COO.

Institutional Ownership:

Through their ownership of 89.59% of UNH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 54.31% of UNH, in contrast to 35.24% held by mutual funds. Shares owned by individuals account for 1.82%. As the largest shareholder in UNH with 8.20% of the stake, The Vanguard Group, Inc. holds 76,924,734 shares worth 76,924,734. A second-largest stockholder of UNH, SSgA Funds Management, Inc., holds 46,274,771 shares, controlling over 4.93% of the firm’s shares. Fidelity Management & Research Co is the third largest shareholder in UNH, holding 44,675,718 shares or 4.76% stake. With a 2.95% stake in UNH, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 27,661,599 shares are owned by the mutual fund manager. The Vanguard 500 Index Fund, which owns about 2.21% of UNH stock, is the second-largest Mutual Fund holder. It holds 20,765,310 shares valued at 10.67 billion. American Funds Growth Fund of Ame holds 1.59% of the stake in UNH, owning 14,917,961 shares worth 7.66 billion.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2022, UNH reported revenue of $80.04B and operating income of $6.84B. Over the past year, revenue came in at $304.58B while operating income stood at $25.34B. It generated $5.07B net income for the quarter, which came to $18.25B over the last twelve months. The EBITDA in the recently reported quarter was $7.64B and diluted EPS was $5.34. EBITDA for the full year was $26.51B.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UNH since 27 analysts follow the stock currently. There are 21 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 4 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With UNH analysts setting a high price target of $632.00 and a low target of $480.00, the average target price over the next 12 months is $584.29. Based on these targets, UNH could surge 18.41% to reach the target high and fall by -10.07% to reach the target low. Reaching the average price target will result in a growth of 9.47% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. UNH will report FY 2022 earnings on 01/17/2023. Analysts have provided yearly estimates in a range of $22.37 being high and $21.55 being low. For UNH, this leads to a yearly average estimate of $21.86. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. UnitedHealth Group Incorporated surprised analysts by $0.36 when it reported $5.57 EPS against a consensus estimate of $5.21. The surprise factor in the prior quarter was $0.13. Based on analyst estimates, the high estimate for the next quarter is $5.68 and the low estimate is $5.28. The average estimate for the next quarter is thus $5.45.

Summary of Insider Activity:

Insiders traded UNH stock several times over the past three months with 25 Buys and 10 Sells. In these transactions, 4,120 shares were bought while 25,822 shares were sold. The number of buy transactions has increased to 113 while that of sell transactions has risen to 70 over the past year. The total number of shares bought during that period was 177,102 while 778,703 shares were sold.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]